|
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
|
Jun 2019
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
|
A Comparison of Outcomes for Cord Blood Transplant and Unrelated Bone Marrow Transplant in Adult Aplastic Anemia
|
Jul 2016
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes
|
Jan 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia
|
Feb 2014
|
Int J Hematol
|
aplastic anemia
|
|
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
|
Oct 2016
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
A Case Series of Post-Transplantation Cyclophosphamide in Unrelated Donor Hematopoietic Cell Transplantation for Aplastic Anemia
|
Jun 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
aplastic anemia
|
|
A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.
|
Jul 2017
|
Cancer
|
myelodysplastic syndromes (MDS)
|
|
5-Azacytidine for the treatment of myelodysplastic syndromes.
|
Apr 2013
|
Expert Opin Pharmacother
|
myelodysplastic syndromes (MDS)
|
|
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials
|
Feb 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
(Auto-)immune signature in aplastic anemia.
|
May 2018
|
Haematologica
|
acute myeloid leukemia (AML)
|
